Bio-Gene 2018 goals & objectives following successful IPO
Filed with ASX · · 3 pages · English
• Identify appropriate potential partners for product evaluation and development. • Demonstrate the activity of our lead molecules Flavocide™ and Qcide™ in an increased number of market segments and target pests via laboratory studies and field trials. • Implement the regulatory required toxicology and environmental safety studies required for product registration filings. • Continue to develop im
Bio-Gene Technology Ltd. on 6ix
Earlier from Bio-Gene Technology
- Bio-Gene announces positive safety results
- Bio-Gene reports positive initial efficacy results
- Bio-Gene extends research collaboration with CSIRO
- Market Release - Admission
Later from Bio-Gene Technology
- Appendix 4C - December 2017
- Pilot study shows Flavocide activity against mosquitos
- Appendix 4D - Half Yearly Report and Accounts - 31/12/17
- Prospectus for Loyalty Options
- Animal health testing and collaboration update
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology